Abstract:Objective To compare the efficacy and safety of short course and high-dose Dexamethasone (HDD) and conventional Prednisone as first-line strategy for children newly diagnosed as primary immune thrombocytopenia (ITP). Methods This study analyzed pre-experimental data of a single center prospective randomized controlled clinical trial.Newly diagnosed but untreated ITP patients enrolled at the Department of Blood and Cancer Center, Beijing Children's Hospital, Capital Medical University from November 2016 to May 2017 were randomized into HDD group[Dexamethasone 0.6 mg/(kg·d), intravenous injection for 4 days]and Prednisone group[Prednisone 2 mg/(kg·d) for 14-28 days and then tapered within 1-2 months, the course of treatment less than 3 months]. Initial response, sustained response and adverse effects after therapy were observed in 2 groups. Results Sixty-six children with ITP were included in the study: 32 patients were in the HDD group and 34 patients were in the Prednisone group.Two groups were matched in the baseline characteristics including gender, age, platelet counts and disease course before therapy and bleeding assessment (all P>0.05). The initial response (the response of HDD group within 10 days of treatment and Prednisone group within 28 days of treatment): overall initial response had no statistical difference between the HDD group and the Prednisone group[90.6%(29/32 cases) vs.100.0%(34/34 cases), χ2=1.528, P>0.05]. HDD group had a lower incidence of complete response compared with that in the Prednisone group[54.4%(19/32 cases) vs.94.1%(32/34 cases), χ2=11.330, P=0.001]; median time of response in two groups showed no statistically difference (2 d vs.1 d, Z=-0.149, P>0.05). There was no significant difference in the recovery of skin and mucosal bleeding after treatment between the Dexamethasone group and the Prednisone group (Z=-1.413, -1.031, all P>0.05). The sustained response (the response lasted for up to 6 months and above): overall and complete sustained response had no statistically difference between the HDD group and the Prednisone group [92.9%(26/28 cases) vs.85.3%(29/34 cases), P=0.594; 78.9% (15/19 cases) vs.81.3%(26/32 cases), P=1.000]. Log-rank test showed no significant difference in the duration of response between 2 groups (P=0.341). The side effects in the Prednisone group included weight gain or Cushing sign (94.1%) and mental and emotional changes (23.5%); in the HDD group 15.6% of children had infection, without other glucocorticoid-related side effects.There was no significant difference in the incidence of infection between two groups[15.6%(5/32 cases) vs.26.5%(9/34 cases), P=0.281]. All of the above infections were of respiratory tract infections and mild gastrointestinal infections. Conclusions Efficacy of the HDD group in the initial and sustained responses is similar, but side effects were apparently lower compared with that in the Prednisone group.However, a large multicenter randomized controlled clinical study is necessary to confirm this result. Key words: Dexamethasone; Child; Immune thrombocytopenia; First-line therapy

Observation on the effects of gamma globulin combined with dexamethasone in children with idiopathic thrombocytopenic purpura

Clinical Observation on Gamma Globulin for the Therapy of Idiopathic Thrombocytopenic Purpura

The Change in Number of Platelet and Megalokaryocyte in Children with Idiopathic Thrombocytopenic Purpura after Treatment

Alteration of Peripheral Blood B1 Cells and Its Associations with Condition and Prognosis of Idiopathic Thrombocytopenic Purpura Patients

Clinical Observation on Severe Henoch-Schonlein Purpura with the Pulse Therapy of Methylprednisolone and Inntravenous Immunoglobulin

Clinical Observation of Traditional Chinese Drug Treatment on Idiopathic Thrombocytopenic Purpura in Children

The changes of CD4+ CDHigh 25 Foxp3+ Treg cell and the Foxp3 gene expression in childhood acute idiopathic thrombocytopenic purpura before and after treatment

Treatment of Childhood Idiopathic Thrombocytopenic Purpura with High-Dose Immunoglobulin

Analysis of Curative Effects of Human Gamma Globulin on Bacterial Pneumonia in Pediatric Patients

[Efficacy and Safety of Low-Dose Rituximab Combined with Different Dosage of Glucocorticoids for Immune Thrombocytopenia].

[Combination therapy of thymosin alpha1 and high dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura].

Efficacy and safety of short course high-dose Dexamethasone as first-line treatment regimen for childhood newly diagnosed immune thrombocytopenia

Analysis on Related Factors Influencing the Efficacy of Glucocorticoid in Treating Idiopathic Thrombocytopenic Purpura

Observation of curative effect of gamma globulin combined with routine antiviral therapy in treatment of viral encephalitis in children

Influence of Infections on Immunoglobulin and Glucocorticoid Efficacy in Children with Idiopathic Thrombocytopenic Purpura

Effect of mycophenolate mofetil combined with methylprednisolone on renal function, D-dimer and interleukin levels in children with Henoch-Schonlein purpura kidney injury

[The impact of human serum immunoglobulin treatment of refractory immune thrombocytopenic purpura. Analysis]

Study of Efficacy of Single Low-Dose Intravenous Immunoglobulin in Elevating Platelet Counts

Clinical Observation of the Combined Regime Including Low-Dose Rituximab and Cyclosporin A(CsA) in the Treatment of Refractory Idiopathic Thrombocytopenic Purpura

Combination therapy of thymosin α1 and high dose dexamethasone in patients with chronic idiopathicthrombocytopenic purpura

[Curative Efficacy of Rituximab for ITP Patients with Different Sensitivity to Hormone].